Have a personal or library account? Click to login
Neoadjuvant gemcitabine and docetaxel in primary breast angiosarcoma revealed complete pathological remission Cover

Neoadjuvant gemcitabine and docetaxel in primary breast angiosarcoma revealed complete pathological remission

Open Access
|Feb 2017

References

  1. 1. Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 2004; 91:237-41.10.1038/sj.bjc.6601920
  2. 2. Moore MP, Kinne DW. Breast sarcoma. Surg Clin North Am. 1996; 76:383-92.10.1016/S0039-6109(05)70445-X
  3. 3. Karlsson P, Holmberg E, Samuelsson A, Johansson KA, Wallgren A. Soft tissue sarcoma after treatment for
  4. 4. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010; 101:401-7.10.1002/jso.2149720119983
  5. 5. Monroe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer. 2003; 97:1832-40.10.1002/cncr.1127712673708
  6. 6. Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008; 26:5269-74.10.1200/JCO.2008.17.314618809609
  7. 7. Italiano A, Cioffi A, Penel N, Levra MG, Delcambre C, Kalbacher E, et al. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer. 2012; 118:3330-6.10.1002/cncr.2659922045619
  8. 8. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, et al. Primary angiosarcomas of the breast. Cancer. 2007; 110:173-8.10.1002/cncr.22784432977917541936
  9. 9. Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer. 2007; 110:648-51.10.1002/cncr.2282217582627
  10. 10. Marchant LK, Orel SG, Perez-Jaffe LA, Reynolds C, Schnall MD. Bilateral angiosarcoma of the breast on MR imaging. AJR Am J Roentgenol. 1997; 169: 1009-10.10.2214/ajr.169.4.93084529308452
  11. 11. Fujita T, Taira N, Ogasawara Y, Omori M, Doihara H. Bilateral angiosarcoma of the breast detected by magnetic resonance imaging during pregnancy. Int J Clin Oncol. 2009; 14:560-3.10.1007/s10147-009-0895-219967497
  12. 12. Boonjunwetwat D. Textbook of Breast Imaging. 1 ed: Chulalongkorn; 2011.
  13. 13. Salas S, Bui B, Stoeckle E, Terrier P, Ranchere-Vince D, Collin F, et al. Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Ann Oncol. 2009; 20: 1127-35.10.1093/annonc/mdn75719179555
  14. 14. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology. 2007; 242: 725-34.10.1148/radiol.242306016317325063
  15. 15. Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute. World J Surg. 2011; 35:2417-21.10.1007/s00268-011-1225-121882024
  16. 16. Liberman L, Dershaw DD, Kaufman RJ, Rosen PP. Angiosarcoma of the breast. Radiology. 1992; 183: 649-54.10.1148/radiology.183.3.15849131584913
  17. 17. Kim YJ LK, Cho YU. MR imaging and spectroscopic finding of primary angiosarcoma of the breast: a case report. J korean Radiol Soc 2006; 54:557-60.10.3348/jkrs.2006.54.6.557
  18. 18. Stacchiotti S, Palassini E, Sanfilippo R, Vincenzi B, Arena MG, Bochicchio AM, et al. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol. 2012; 23:501-8.10.1093/annonc/mdr06621464156
  19. 19. Hensley ML, Blessing JA, Mannel R, Rose PG. Fixeddose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008; 109:329-34.10.1016/j.ygyno.2008.03.010250472718534250
  20. 20. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007; 25:2755-63.10.1200/JCO.2006.10.411717602081
  21. 21. Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol. 2004; 22: 1706-12.10.1200/JCO.2004.08.04315117993
  22. 22. Shkoukani MA, Carron MA, Tulunay O, Kucuk O, Lin HS. Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen. Ear Nose Throat J. 2011; 90:E26-9.10.1177/01455613110900011821229496
  23. 23. Wilson R, Glaros S, Brown RK, Michael C, Reisman D. Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere. Lung Cancer. 2008; 61:131-6.10.1016/j.lungcan.2007.12.00618243404
DOI: https://doi.org/10.5372/1905-7415.0703.199 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 449 - 454
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Thiva Kiatpanabhikul, Chanida Vinayanuwattikun, Pimchandr Chakkabat, Voranuch Thanakit, Apichai Angspatt, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.